Scientists recently conducted a study on the thiazolidinediones drugs, which are used to treat type 2 diabetics. The drugs, including Avandia, were found to cause major bone fracture risks among women patients potentially worsening a patient’s condition.
Women who consume Avandia (rosiglitazone) or Actos (pioglitazone) for their type 2 diabetes condition may be at an increased risk of bone fractures among their hips as well as other body parts, according to a study recently published in the Canadian Medical Association Journal (CMAJ).
This is a preview of
Type 2 DIabetes Woman At Risk For Bone Fracture While Consuming Avandia and Actos
.
Read the full post (548 words, estimated 2:12 mins reading time)Share This